Cannabis Earnings

PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results
Body and Mind Narrows Loss By 30% YoY In Q3, Doubles Down On Streamlining Operations
Marijuana Fintech Co. POSaBIT Reports 67% YoY Drop In Q1 Revenue, Renews Focus On Sustainable Profitability And Growth
Body and Mind Narrows Loss By 30% YoY In Q3, Doubles Down On Streamlining Operations
Marijuana Fintech Co. POSaBIT Reports 67% YoY Drop In Q1 Revenue, Renews Focus On Sustainable Profitability And Growth
Scotts Miracle-Gro Reaffirms $1B Cash Flow Target, Reduces EBITDA Earnings Expectations, Cost-Saving On Track
Canadian Weed Producer Red White & Bloom Narrows Loss, Reports 15% YoY Drop In Q1 Revenue As It Wraps Up Aleafia Acquisition

Cannabis Earnings Recent News

Acreage's Q1 Revenue Slips 19% YoY But CEO Foresees 'Significant Growth Opportunities' As Canopy Growth Strategy Moves Forward
Multi-state cannabis operator Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), reported on Friday its financial results for the first quarter ended March 31, 2024. "In the first quarter, we diligently focused on cash preservation, implementing cost-saving measures, and honing our business strategy," Dennis Curran, the company's CEO, said. "Our Northeastern footprint was a focal point with our entry into the New York adult-use wholesale market and the conversion of our third dispensary in Connecticut to a hybrid model serving both patients and consumers."
Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States 'Primary Growth Drivers'
Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its first-quarter 2024 results for the three months ended March 31, 2024.The Medford, Oregon-based company reported record quarterly revenue of $6.7 million, compared to $6 million in the three months ended April 30, 2023, representing a year-over-year increase of 11%."This was another exciting quarter with record revenue and aEBITDA despite the year-ago comparison period including April instead of January; April is seasonally a stronger month for the industry," Obie Strickler, CEO of Grown Rogue, said. "In addition, we achieved record indoor revenue in Michigan and Oregon during the quarter and are thrilled that an increasing number of customers in competitive markets are choosing our products which means we are continuing to bring them value."
SLANG Worldwide Q1 Revenue Drops 35% YoY, Touts E-Commerce Segment Improvement Thanks To CBD Gummy Brand
Canopy Growth Reports 7% YoY Increase In Q4 Net Revenue, Continues Focus On Innovation In Canada And International Expansion
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Thursday financial results for the fourth quarter and fiscal year ended March 31, 2024.Fourth quarter net revenue for the company's subsidiary Storz & Bickel which manufactures high-end and medically certified cannabis vaporizers surged 43% year-over-year to CA$22million ($16 million).Moreover, Canada's cannabis net revenue in the same period increased 4% year-over-year led by a 16% increase in the Canada medical cannabis business that saw its 5th consecutive quarter of revenue growth.
Nextleaf's Q2 Net Revenue Up 57% YoY, Reports Growth Across 'Key Categories'
Cannabis processor Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) reported on Wednesday its financial results for the second quarter ended March 31, 2024. The Vancouver-based company said it has achieved 7% sequential and 57% year-over-year revenue growth, hitting a record $3.4 million in net revenue.
Decibel Cannabis Reports 16% YoY Drop In Q1 Revenue, CEO Expects Improved Q2 And 'Continued Path To Sustainable Growth And Profitability'
Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF), a maker of premium cannabis and extract manufactured products, announced on Wednesday its unaudited interim financial results for the three months ending March 31, 2024. The Calgary, Alberta-based company reported a year-over-year decrease of 16% in net revenue to $21 million. Benjamin Sze, the company's CEO said that "despite the drop in revenue, we remain one of Canada's top brands by market share." The company boasted a national market share of 6% in the first quarter, placing it as the 4th largest licensed producer in Canada by market share, the company said in a press release.
Cannabis Producer Vext Reports YoY Decline In Q1, Announces $2M Standby Credit Facility Ahead Of Ohio Rec Market Launch
Cannabis operator with vertical operations in Arizona and Ohio, Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Wednesday its first quarter financial results for the three months ended March 31, 2024."The first quarter of 2024 continued to present consumer-related challenges to all operators, with the Arizona market overall experiencing another decline in quarterly revenue," said Eric Offenberger, CEO of Vext.
Weedmaps Reports YoY Improvements In Adjusted EBITDA, Reports Drop In Q1 Revenue
WM Technology, Inc. (NASDAQ: MAPS) - also known as Weedmaps - announced on Friday its first quarter financial results for the three months ended March 31, 2024 and the full year ending December 31, 2023."I am proud of the progress and results our team was able to deliver to start the year, and more importantly, we are pleased that the net effects of our revenue recognition review were relatively minimal," said Doug Francis, executive chair of WM Technology. "We believe our continued focus on developing strong client relationships and commitment to operational efficiency have positioned the Company to continue to profitably build its base of quality clients in this dynamic industry over time."
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.
Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'
Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its first quarter financial results for the three months ended March 31, 2024. The Toronto-based company reported a total revenue of CA$16.4 million ($12 million) (net revenue of CA$12.7 million, before excise duties and discounts), representing a 9% year-over-year increase. "Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024," George Scorsis, the company's chair and CEO, said. "With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1."
Marijuana Extraction Company Ayurcann Reports 127.7% YoY Revenue Growth For The Third Quarter
Canadian Edibles Producer Indiva Reports Modest Q1 Results, Eyes Strong 2024 After Strategic Realignments
Indiva Q1 2024 results show growth in core brands, offsetting losses from Wana and lozenges, boosting market share. Read now!
Cannabis Tech Firm Agrify Significantly Cuts Loss, But Also Sees Revenue Decline
Cannabis Company 4Front Reports 28% YoY Drop In Q1 Revenue While Net Loss Grows, CEO Optimistic With Biden's Marijuana Rescheduling News
Vertically integrated multi-state cannabis operator and retailer 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) announced on Friday its results for the quarter ended March 31, 2024. "We've had an encouraging start to the year, energized by the fresh dynamics introduced with my recent appointment as CEO," the company's Andrew Thut said. "In just a few weeks, we've seen tangible improvements in our financial health, evidenced by reduced operational costs and effective management of working capital."
Blüm Holdings Q1 Revenue Drop 16% YoY, Eliminates Non-Performing Legacy Operations, Reduces Net Loss
Canadian Marijuana Company Rubicon Organics Reports Flat Revenue, Adjusted EBITDA Loss, Provides Positive Outlook
TILT Holdings Q1 Revenue Down, Net Loss Up Due To Lower Prices, Optimistic On Rescheduling, Plans To Address Debt
Delta 9 Cannabis' Q1 Revenue Drops Slightly YoY, Gross Profit Grows 10%
Delta 9 Cannabis Inc. announced on Wednesday financial and operating results for the three months ending March 31, 2024."During the first quarter, we continued to focus on sustaining revenues across our core business units while optimizing our margins," John Arbuthnot, CEO of Delta 9, said. "We will continue our relentless focus on cost and operational efficiencies and strengthening our balance sheet to deliver sustained, profitable growth for our shareholders
California Cannabis Co. Gold Flora Reports 150% YoY Increase In Q1 Gross Profit, Trims Loss Sequentially
California cannabis company Gold Flora Corporation (Cboe Canada: GRAM) announced on Wednesday its first quarter financial results for the three months ended March 31, 2024. "Our Q1 2024 results reflect the work we have done to scale our operations to leverage the solid foundation we have built and realize the significant benefits of our vertical integration," Laurie Holcomb, the company's CEO, said.Gold Flora significantly expanded its cultivation operations with the introduction of the Gramlin brand. The expansion increased the canopy space to 107k square feet, a more than double increment from the previous year. The launch of Gramlin, targeting high-volume consumers with affordable pricing and trendy packaging, aims to elevate sales of in-house products from 22% to 30%, as Benzinga's Nicolás Jose Rodriguez highlighted in his recent recap of cannabis analysts' reports.
AYR Wellness Improves Financial Position YoY, Q1 Revenue And Gross Profit In Anticipation Of OH, FL And PA Cannabis Market Launches
Cannabis multi-state operator AYR Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) reported on Wednesday the first quarter financial results for the three months ended March 31, 2024."2024 continues to be about execution for AYR, furthering the progress we made in 2023 by focusing on improving product quality and consistency, building a loyal retail customer base, rebuilding our CPG brand platform, and continuing to prioritize cost controls," David Goubert, president & CEO of AYR, said.
Cresco Labs CEO Touts 10x Increase In Operating Cash Flow YoY As Cannabis Company Reports Q1 Results
Cannabis producer Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced on Wednesday its financial and operating results for the first quarter ended March 31, 2024. "I want to thank the Cresco team for taking our learnings from the Year-of-the-Core, making them a part of our DNA and producing such a strong start to 2024," Charles Bachtell, CEO of Cresco Labs, said. "The continued development of our teams' capabilities and our relentless focus on efficient execution is leading to very strong performance across our retail and branded product business resulting in a 10x increase in operating cash flow year-over-year."
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
Jones Soda's Marijuana Drinks Bring In 200% Higher Q1 Revenue, Co. Eyes Expansion And Praises New Hemp Delta-9 Products